141
Participants
Start Date
December 15, 2016
Primary Completion Date
August 18, 2017
Study Completion Date
September 20, 2024
Troriluzole
Randomization Phase: Neat (i.e., drug substance without excipients); loose filled capsule.
Placebo
Drug: Placebo Randomization Phase: Matching placebo loose filled capsule.
Troriluzole
OLE phase: Neat capsule or formulated capsule (i.e., drug substance with excipients).
Columbia University, New York
University of Rochester Medical Center, Rochester
Johns Hopkins University, Baltimore
Emory University, Atlanta
University of Florida, Gainesville
University of South Florida, Tampa
University of Michigan, Ann Arbor
Northwestern University, Chicago
University of Chicago, Chicago
University of Texas Southwestern, Dallas
Houston Methodist Research Center, Houston
University of Colorado Denver, Denver
St. Joseph's Hospital and Medical Center, Phoenix
University of California, Los Angeles, Los Angeles
CNS Trial, Long Beach
University of California, San Francisco, San Francisco
Harvard University (Massachusetts General Hospital), Boston
Harvard University (Beth Israel Deaconess Medical Center), Boston
Lead Sponsor
Biohaven Pharmaceuticals, Inc.
INDUSTRY